カテゴリー： QYResearch, その他産業, 世界

世界の新型コロナウイルス感染症治療薬市場インサイト及び予測（経口、注射）

◆英語タイトル：Global Covid-19 Treatment Medicine Market Insights, Forecast to 2028
	◆商品コード：QY22JL3788 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：86 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：新技術

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、新型コロナウイルス感染症治療薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に新型コロナウイルス感染症治療薬の世界市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「軽度-中等度新型コロナウイルス感染症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
新型コロナウイルス感染症治療薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの新型コロナウイルス感染症治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

新型コロナウイルス感染症治療薬のグローバル主要企業には、Pfizer (Paxlovid)、VEKLURY (Remdesivir)、Lagevrio、GSK (Sotrovimab)、Regeneron (Ronapreve)、Yiling Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

新型コロナウイルス感染症治療薬市場は、種類と用途によって区分されます。世界の新型コロナウイルス感染症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
経口、注射

【用途別セグメント】
軽度-中等度新型コロナウイルス感染症、重症患者

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 新型コロナウイルス感染症治療薬製品概要
- 種類別市場（経口、注射）
- 用途別市場（軽度-中等度新型コロナウイルス感染症、重症患者）
- 調査の目的
・エグゼクティブサマリー
- 世界の新型コロナウイルス感染症治療薬販売量予測2017-2028
- 世界の新型コロナウイルス感染症治療薬売上予測2017-2028
- 新型コロナウイルス感染症治療薬の地域別販売量
- 新型コロナウイルス感染症治療薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別新型コロナウイルス感染症治療薬販売量
- 主要メーカー別新型コロナウイルス感染症治療薬売上
- 主要メーカー別新型コロナウイルス感染症治療薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（経口、注射）
- 新型コロナウイルス感染症治療薬の種類別販売量
- 新型コロナウイルス感染症治療薬の種類別売上
- 新型コロナウイルス感染症治療薬の種類別価格
・用途別市場規模（軽度-中等度新型コロナウイルス感染症、重症患者）
- 新型コロナウイルス感染症治療薬の用途別販売量
- 新型コロナウイルス感染症治療薬の用途別売上
- 新型コロナウイルス感染症治療薬の用途別価格
・北米市場
- 北米の新型コロナウイルス感染症治療薬市場規模（種類別、用途別）
- 主要国別の新型コロナウイルス感染症治療薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの新型コロナウイルス感染症治療薬市場規模（種類別、用途別）
- 主要国別の新型コロナウイルス感染症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の新型コロナウイルス感染症治療薬市場規模（種類別、用途別）
- 主要国別の新型コロナウイルス感染症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の新型コロナウイルス感染症治療薬市場規模（種類別、用途別）
- 主要国別の新型コロナウイルス感染症治療薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの新型コロナウイルス感染症治療薬市場規模（種類別、用途別）
- 主要国別の新型コロナウイルス感染症治療薬市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer (Paxlovid)、VEKLURY (Remdesivir)、Lagevrio、GSK (Sotrovimab)、Regeneron (Ronapreve)、Yiling Pharmaceutical
・産業チェーン及び販売チャネル分析
- 新型コロナウイルス感染症治療薬の産業チェーン分析
- 新型コロナウイルス感染症治療薬の原材料
- 新型コロナウイルス感染症治療薬の生産プロセス
- 新型コロナウイルス感染症治療薬の販売及びマーケティング
- 新型コロナウイルス感染症治療薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 新型コロナウイルス感染症治療薬の産業動向
- 新型コロナウイルス感染症治療薬のマーケットドライバー
- 新型コロナウイルス感染症治療薬の課題
- 新型コロナウイルス感染症治療薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Covid-19 Treatment Medicine Market
Due to the COVID-19 pandemic, the global Covid-19 Treatment Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Oral accounting for % of the Covid-19 Treatment Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Mild-to-Moderate COVID-19 segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Treatment Medicine market size is valued at US$ million in 2021, while the US and Europe Covid-19 Treatment Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Covid-19 Treatment Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Covid-19 Treatment Medicine include Pfizer (Paxlovid), VEKLURY (Remdesivir), Lagevrio, GSK (Sotrovimab), Regeneron (Ronapreve) and Yiling Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Covid-19 Treatment Medicine Scope and Segment
Covid-19 Treatment Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Covid-19 Treatment Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Injetion
Segment by Application
Mild-to-Moderate COVID-19
Severe Patient
By Company
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Covid-19 Treatment Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Treatment Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injetion
1.3 Market by Application
1.3.1 Global Covid-19 Treatment Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Mild-to-Moderate COVID-19
1.3.3 Severe Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Covid-19 Treatment Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Covid-19 Treatment Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Covid-19 Treatment Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Covid-19 Treatment Medicine Sales by Region
2.4.1 Global Covid-19 Treatment Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Covid-19 Treatment Medicine by Region (2023-2028)
2.5 Global Covid-19 Treatment Medicine Revenue by Region
2.5.1 Global Covid-19 Treatment Medicine Revenue by Region (2017-2022)
2.5.2 Global Covid-19 Treatment Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Covid-19 Treatment Medicine Sales by Manufacturers
3.1.1 Global Top Covid-19 Treatment Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Covid-19 Treatment Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Covid-19 Treatment Medicine in 2021
3.2 Global Covid-19 Treatment Medicine Revenue by Manufacturers
3.2.1 Global Covid-19 Treatment Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Covid-19 Treatment Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Covid-19 Treatment Medicine Revenue in 2021
3.3 Global Covid-19 Treatment Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Covid-19 Treatment Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Covid-19 Treatment Medicine Sales by Type
4.1.1 Global Covid-19 Treatment Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Covid-19 Treatment Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
4.2 Global Covid-19 Treatment Medicine Revenue by Type
4.2.1 Global Covid-19 Treatment Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Covid-19 Treatment Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Covid-19 Treatment Medicine Price by Type
4.3.1 Global Covid-19 Treatment Medicine Price by Type (2017-2022)
4.3.2 Global Covid-19 Treatment Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Covid-19 Treatment Medicine Sales by Application
5.1.1 Global Covid-19 Treatment Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Covid-19 Treatment Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
5.2 Global Covid-19 Treatment Medicine Revenue by Application
5.2.1 Global Covid-19 Treatment Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Covid-19 Treatment Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Covid-19 Treatment Medicine Price by Application
5.3.1 Global Covid-19 Treatment Medicine Price by Application (2017-2022)
5.3.2 Global Covid-19 Treatment Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Covid-19 Treatment Medicine Market Size by Type
6.1.1 North America Covid-19 Treatment Medicine Sales by Type (2017-2028)
6.1.2 North America Covid-19 Treatment Medicine Revenue by Type (2017-2028)
6.2 North America Covid-19 Treatment Medicine Market Size by Application
6.2.1 North America Covid-19 Treatment Medicine Sales by Application (2017-2028)
6.2.2 North America Covid-19 Treatment Medicine Revenue by Application (2017-2028)
6.3 North America Covid-19 Treatment Medicine Market Size by Country
6.3.1 North America Covid-19 Treatment Medicine Sales by Country (2017-2028)
6.3.2 North America Covid-19 Treatment Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Covid-19 Treatment Medicine Market Size by Type
7.1.1 Europe Covid-19 Treatment Medicine Sales by Type (2017-2028)
7.1.2 Europe Covid-19 Treatment Medicine Revenue by Type (2017-2028)
7.2 Europe Covid-19 Treatment Medicine Market Size by Application
7.2.1 Europe Covid-19 Treatment Medicine Sales by Application (2017-2028)
7.2.2 Europe Covid-19 Treatment Medicine Revenue by Application (2017-2028)
7.3 Europe Covid-19 Treatment Medicine Market Size by Country
7.3.1 Europe Covid-19 Treatment Medicine Sales by Country (2017-2028)
7.3.2 Europe Covid-19 Treatment Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Covid-19 Treatment Medicine Market Size by Type
8.1.1 Asia Pacific Covid-19 Treatment Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Covid-19 Treatment Medicine Market Size by Application
8.2.1 Asia Pacific Covid-19 Treatment Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Covid-19 Treatment Medicine Market Size by Region
8.3.1 Asia Pacific Covid-19 Treatment Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Covid-19 Treatment Medicine Market Size by Type
9.1.1 Latin America Covid-19 Treatment Medicine Sales by Type (2017-2028)
9.1.2 Latin America Covid-19 Treatment Medicine Revenue by Type (2017-2028)
9.2 Latin America Covid-19 Treatment Medicine Market Size by Application
9.2.1 Latin America Covid-19 Treatment Medicine Sales by Application (2017-2028)
9.2.2 Latin America Covid-19 Treatment Medicine Revenue by Application (2017-2028)
9.3 Latin America Covid-19 Treatment Medicine Market Size by Country
9.3.1 Latin America Covid-19 Treatment Medicine Sales by Country (2017-2028)
9.3.2 Latin America Covid-19 Treatment Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Covid-19 Treatment Medicine Market Size by Type
10.1.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Covid-19 Treatment Medicine Market Size by Application
10.2.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Covid-19 Treatment Medicine Market Size by Country
10.3.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer (Paxlovid)
11.1.1 Pfizer (Paxlovid) Corporation Information
11.1.2 Pfizer (Paxlovid) Overview
11.1.3 Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer (Paxlovid) Recent Developments
11.2 VEKLURY (Remdesivir)
11.2.1 VEKLURY (Remdesivir) Corporation Information
11.2.2 VEKLURY (Remdesivir) Overview
11.2.3 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 VEKLURY (Remdesivir) Recent Developments
11.3 Lagevrio
11.3.1 Lagevrio Corporation Information
11.3.2 Lagevrio Overview
11.3.3 Lagevrio Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Lagevrio Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Lagevrio Recent Developments
11.4 GSK (Sotrovimab)
11.4.1 GSK (Sotrovimab) Corporation Information
11.4.2 GSK (Sotrovimab) Overview
11.4.3 GSK (Sotrovimab) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK (Sotrovimab) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK (Sotrovimab) Recent Developments
11.5 Regeneron (Ronapreve)
11.5.1 Regeneron (Ronapreve) Corporation Information
11.5.2 Regeneron (Ronapreve) Overview
11.5.3 Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Regeneron (Ronapreve) Recent Developments
11.6 Yiling Pharmaceutical
11.6.1 Yiling Pharmaceutical Corporation Information
11.6.2 Yiling Pharmaceutical Overview
11.6.3 Yiling Pharmaceutical Covid-19 Treatment Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Yiling Pharmaceutical Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yiling Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Covid-19 Treatment Medicine Industry Chain Analysis
12.2 Covid-19 Treatment Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Covid-19 Treatment Medicine Production Mode & Process
12.4 Covid-19 Treatment Medicine Sales and Marketing
12.4.1 Covid-19 Treatment Medicine Sales Channels
12.4.2 Covid-19 Treatment Medicine Distributors
12.5 Covid-19 Treatment Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Covid-19 Treatment Medicine Industry Trends
13.2 Covid-19 Treatment Medicine Market Drivers
13.3 Covid-19 Treatment Medicine Market Challenges
13.4 Covid-19 Treatment Medicine Market Restraints
14 Key Findings in The Global Covid-19 Treatment Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Covid-19 Treatment Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injetion
Table 4. Global Covid-19 Treatment Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Covid-19 Treatment Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Covid-19 Treatment Medicine Sales by Region (2017-2022) & (K Units)
Table 7. Global Covid-19 Treatment Medicine Sales Market Share by Region (2017-2022)
Table 8. Global Covid-19 Treatment Medicine Sales by Region (2023-2028) & (K Units)
Table 9. Global Covid-19 Treatment Medicine Sales Market Share by Region (2023-2028)
Table 10. Global Covid-19 Treatment Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Covid-19 Treatment Medicine Revenue Market Share by Region (2017-2022)
Table 12. Global Covid-19 Treatment Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Covid-19 Treatment Medicine Revenue Market Share by Region (2023-2028)
Table 14. Global Covid-19 Treatment Medicine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Covid-19 Treatment Medicine Sales Share by Manufacturers (2017-2022)
Table 16. Global Covid-19 Treatment Medicine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Covid-19 Treatment Medicine Revenue Share by Manufacturers (2017-2022)
Table 18. Covid-19 Treatment Medicine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Covid-19 Treatment Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Covid-19 Treatment Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment Medicine as of 2021)
Table 21. Covid-19 Treatment Medicine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Covid-19 Treatment Medicine Product Offered
Table 23. Date of Manufacturers Enter into Covid-19 Treatment Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 26. Global Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 27. Global Covid-19 Treatment Medicine Sales Share by Type (2017-2022)
Table 28. Global Covid-19 Treatment Medicine Sales Share by Type (2023-2028)
Table 29. Global Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Covid-19 Treatment Medicine Revenue Share by Type (2017-2022)
Table 32. Global Covid-19 Treatment Medicine Revenue Share by Type (2023-2028)
Table 33. Covid-19 Treatment Medicine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Covid-19 Treatment Medicine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 36. Global Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 37. Global Covid-19 Treatment Medicine Sales Share by Application (2017-2022)
Table 38. Global Covid-19 Treatment Medicine Sales Share by Application (2023-2028)
Table 39. Global Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Covid-19 Treatment Medicine Revenue Share by Application (2017-2022)
Table 42. Global Covid-19 Treatment Medicine Revenue Share by Application (2023-2028)
Table 43. Covid-19 Treatment Medicine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Covid-19 Treatment Medicine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 46. North America Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 47. North America Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 50. North America Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 51. North America Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 54. North America Covid-19 Treatment Medicine Sales by Country (2023-2028) & (K Units)
Table 55. North America Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Covid-19 Treatment Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Covid-19 Treatment Medicine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Covid-19 Treatment Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Covid-19 Treatment Medicine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Covid-19 Treatment Medicine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Covid-19 Treatment Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Covid-19 Treatment Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Covid-19 Treatment Medicine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Covid-19 Treatment Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Covid-19 Treatment Medicine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Covid-19 Treatment Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Covid-19 Treatment Medicine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Covid-19 Treatment Medicine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Covid-19 Treatment Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Covid-19 Treatment Medicine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Covid-19 Treatment Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer (Paxlovid) Corporation Information
Table 106. Pfizer (Paxlovid) Description and Major Businesses
Table 107. Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer (Paxlovid) Recent Developments
Table 110. VEKLURY (Remdesivir) Corporation Information
Table 111. VEKLURY (Remdesivir) Description and Major Businesses
Table 112. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. VEKLURY (Remdesivir) Recent Developments
Table 115. Lagevrio Corporation Information
Table 116. Lagevrio Description and Major Businesses
Table 117. Lagevrio Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Lagevrio Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Lagevrio Recent Developments
Table 120. GSK (Sotrovimab) Corporation Information
Table 121. GSK (Sotrovimab) Description and Major Businesses
Table 122. GSK (Sotrovimab) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. GSK (Sotrovimab) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. GSK (Sotrovimab) Recent Developments
Table 125. Regeneron (Ronapreve) Corporation Information
Table 126. Regeneron (Ronapreve) Description and Major Businesses
Table 127. Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Regeneron (Ronapreve) Recent Developments
Table 130. Yiling Pharmaceutical Corporation Information
Table 131. Yiling Pharmaceutical Description and Major Businesses
Table 132. Yiling Pharmaceutical Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Yiling Pharmaceutical Covid-19 Treatment Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Yiling Pharmaceutical Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Covid-19 Treatment Medicine Distributors List
Table 138. Covid-19 Treatment Medicine Customers List
Table 139. Covid-19 Treatment Medicine Market Trends
Table 140. Covid-19 Treatment Medicine Market Drivers
Table 141. Covid-19 Treatment Medicine Market Challenges
Table 142. Covid-19 Treatment Medicine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Treatment Medicine Product Picture
Figure 3. Global Covid-19 Treatment Medicine Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injetion Product Picture
Figure 5. Global Covid-19 Treatment Medicine Market Share by Application in 2021 & 2028
Figure 6. Mild-to-Moderate COVID-19
Figure 7. Severe Patient
Figure 8. Covid-19 Treatment Medicine Report Years Considered
Figure 9. Global Covid-19 Treatment Medicine Sales 2017-2028 (K Units)
Figure 10. Global Covid-19 Treatment Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Covid-19 Treatment Medicine Revenue 2017-2028 (US$ Million)
Figure 12. Global Covid-19 Treatment Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Covid-19 Treatment Medicine Sales Market Share by Region (2017-2022)
Figure 14. Global Covid-19 Treatment Medicine Sales Market Share by Region (2023-2028)
Figure 15. North America Covid-19 Treatment Medicine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Covid-19 Treatment Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Covid-19 Treatment Medicine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Covid-19 Treatment Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Covid-19 Treatment Medicine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Covid-19 Treatment Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Covid-19 Treatment Medicine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Covid-19 Treatment Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Covid-19 Treatment Medicine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Covid-19 Treatment Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Covid-19 Treatment Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Covid-19 Treatment Medicine in the World: Market Share by Covid-19 Treatment Medicine Revenue in 2021
Figure 27. Global Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 29. Global Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 30. Global Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 31. Global Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 32. North America Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 33. North America Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 34. North America Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 35. North America Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 36. North America Covid-19 Treatment Medicine Sales Share by Country (2017-2028)
Figure 37. North America Covid-19 Treatment Medicine Revenue Share by Country (2017-2028)
Figure 38. United States Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 41. Europe Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 43. Europe Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Covid-19 Treatment Medicine Sales Share by Country (2017-2028)
Figure 45. Europe Covid-19 Treatment Medicine Revenue Share by Country (2017-2028)
Figure 46. Germany Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 47. France Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Covid-19 Treatment Medicine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Covid-19 Treatment Medicine Revenue Share by Region (2017-2028)
Figure 57. China Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 60. India Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Covid-19 Treatment Medicine Sales Share by Country (2017-2028)
Figure 71. Latin America Covid-19 Treatment Medicine Revenue Share by Country (2017-2028)
Figure 72. Mexico Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Covid-19 Treatment Medicine Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Covid-19 Treatment Medicine Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Covid-19 Treatment Medicine Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Covid-19 Treatment Medicine Revenue Share by Country (2017-2028)
Figure 82. Turkey Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Covid-19 Treatment Medicine Revenue (2017-2028) & (US$ Million)
Figure 85. Covid-19 Treatment Medicine Value Chain
Figure 86. Covid-19 Treatment Medicine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の新型コロナウイルス感染症治療薬市場インサイト及び予測（経口、注射）(Global Covid-19 Treatment Medicine Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の新型コロナウイルス感染症治療薬市場インサイト及び予測（経口、注射）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp